A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. | LitMetric

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 197

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1075
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3195
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 317
Function: require_once

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. | LitMetric

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.

John Y Li , Samuel R Perry , Vanessa Muniz-Medina , Xinzhong Wang , Leslie K Wetzel , Marlon C Rebelatto , Mary Jane Masson Hinrichs , Binyam Z Bezabeh , Ryan L Fleming , Nazzareno Dimasi , Hui Feng , Dorin Toader , Andy Q Yuan , Lan Xu , Jia Lin , Changshou Gao , Herren Wu , Rakesh Dixit , Jane K Osbourn , Steven R Coats

Cancer Cell

Published: June 2019

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Download full-text PDF
Source

http://dx.doi.org/10.1016/j.ccell.2019.05.010 DOI Listing

Publication Analysis

Top Keywords

biparatopic her2-targeting

4

her2-targeting antibody-drug

4

antibody-drug conjugate

4

conjugate induces

4

induces tumor

4

tumor regression

4

regression primary

4

primary models

4

models refractory

4

refractory ineligible

4

Similar Publications